Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMCOMBIN: Simvastatin add-on to Interferon-beta-1a in RRMS
NCT00492765Phase 4Completed
- Sponsor
- Biogen
- Start
- Feb 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of simvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Biogen. Started Feb 2006; status: completed.
02
Drugs
simvastatin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00492765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492765.